Tom Ruby
Scientist, entrepreneur, former team handball player, amateur opera singer
@robertcoffin.bsky.social
Ex-academic (many years ago) & biotech entrepreneur, including at Biovex & $REPL inc
@noomanhaque.bsky.social
Investor in life sciences & tech. Innovation policy. Fellow at Cambridge University (LCC). Married to a better economist. Cooking. Sports, but badly. ICI was the perfect company once
@michaelwong.bsky.social
Biotech venture creation and pharma partnerships at Flagship Pioneering. Company builder by practice, placental biologist by training. 🇨🇦
@mppai.bsky.social
Biotech investor relations. Voracious reader, eater & wine drinker. Personal account; posts & opinions are my own. she/her
@dereklowe.bsky.social
Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. [email protected] and on Signal at Dblowe.18 All opinions are mine; I don’t speak for my employer in any way.
@flaviucipcigan.bsky.social
Building AIs for scientific discovery at IBM Research & AI Alliance. Discovered antibiotics and materials for carbon capture. Tango dancer. See more at flaviucipcigan.com. Opinions my own.
@caitlinmellor.bsky.social
ML/DL programmer in AI & drug discovery 🧬 PhD researcher in London 👩💻🤍 ✉️ [email protected]
@mpapadourakis.bsky.social
Postdoctoral associate in Hellenic Mediterranean University and Biomedical Research Foundation Academy of Athens. Passionate for computational drug design
@ardemp.bskyverified.social
Scripps Research Professor. HHMI Investigator. Nobel Prize Physiology or Medicine 2021. Opinions my own.
@carolynbertozzi.bskyverified.social
Baker Family Director, Sarafan ChEM-H, Stanford University and HHMI; EIC of ACS Cent Sci; All views and opinions expressed are my own.
@lisamjarvis.bsky.social
Chicago-based health & science columnist for Bloomberg Opinion @opinion.bsky.social. Writing about public health, medicine, emerging technologies (Crispr!), biotech & pharma. opinions=mine, She/her. Signal: lisajarvis.77
@adamfeuerstein.bsky.social
Reporter at STAT. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. Said one analyst: The likes of Adam Feuerstein attack viciously.
@lizbwood.bsky.social
Founder & CEO @jura.bsky.social | Full-stack probabilistic machine learning for the development of genetic medicines | NYC & Basel & Boston
@shafferbiotech.bsky.social
Biotech entrepreneur and consultant. Biochem PhD. Opinions strictly my own.
@albertvilella.bsky.social
Bioinformatics Scientist / Next Generation Sequencing, Single Cell and Spatial Biology, Next Generation Proteomics, Liquid Biopsy, SynBio, Compute Acceleration in biotech // http://albertvilella.substack.com
@agenemachine.bsky.social
Protein engineer (Rosetta/ML/wet lab) working on a NewCo building targeted chemotherapy for solid tumours (esp. PDAC) using ADEPT — loops and buried polar groups are a feature, not a bug.
@jordixiol.bsky.social
Science, history, and drug development | https://vineyardbooks.substack.com/
@elaineywchen.bsky.social
Reporter @statnews.com covering drugs and the biopharma industry | signal: elaineywchen.70
@ericlubeck.bsky.social
biology 🧬, microscopes 🔬, and computers 🖥️. Preferably all at once.
@vikramsundar.bsky.social
Researcher in ML and Structural Biology | MIT CSB Student in Kevin Esvelt's lab and Hertz Fellow
@drannecarpenter.bsky.social
Dedicated to drug discovery, enthralled by science. 5 kids. She. SAB Recursion. Founder SyzOnc. Lab at Broad Institute. Opinions my own.
@dhanda.bsky.social
CEO | Founder | Biotech | Boston | Film | Author Current: Co-founder, CEO: syntis.bio Co-founder, chairman: BLASTID Past: Co-founder, founding CEO, Sherlock Biosciences
@robinfriedman.bsky.social
Computational biologist in industry; views are my own. Wide interests in genomics, immunotherapy, pharmacology, biotech, single cell methods, and reproductive biology.
@laureloldach.bsky.social
Biochemistry & instrumentation reporter at Chemical & Engineering News. Signal: Laurel_Oldach.07
@pearlf.bsky.social
From Boston, MA. I'm @pearlf on the other blue-colored place. Founder of Cambridge BioPartners, Inc. I post mostly healthcare-related and biotech-related news items.
@franksdavid.bsky.social
Biotech R&D strategy @ Pharmagellan. Prof of Practice of Biotech @ Tufts Biology. Bio, books, blog & more at www.pharmagellan.com. #biosky
@matthewherper.bsky.social
I write about medicine at STAT. This is biology's century. Every data point has a face.
@rickberke.bsky.social
Co-founder & Executive Editor, STAT (www.statnews.com) @statnews.bsky.social Longtime reporter/editor NYT
@drrichjlaw.bsky.social
Chief Business Officer of Haya Therapeutics! (formerly Exscientia/Recursion CBO), computational chemist by training (Oxford, UCSD, LLNL & Evotec), bike racer, ex-Oxford rower & LFC fan! #YNWA.
@dbsable.bsky.social
Doctor/teacher/writer. Ob/gyn and IVF doc. Roadie for Priya Mayadas. Adjunct @Columbia https://dbsable.substack.com
@biotechtv.bsky.social
News, stories, and educational videos about the biotechnology sector. Bringing biotech to life. 📺
@synbiobeta.bsky.social
Synthetic Biology Events & Industry Information 🌍 Global Synthetic Biology Conference 📅 May 5-8, 2025 in San Jose Join us! #SynBioBeta2025 https://www.synbiobeta.com/events/synbiobeta-2025
@martinbjensen.bsky.social
Aging, Systems Biology, Gene Therapy. CSO @GordianBio, doing mosaic therapeutic screens in vivo. Also @NornGroup/Impetus Grants. Previously K99 Fellow @Buck Institute.
@amaha.bsky.social
Entrepreneur, Board Member, Author, Physician Co-founder of nine biotech startups developing novel platforms and therapies. Biotech Board member and advisor; Author of Quiet Leader Loud Results (Post Hill Press, 2022) www.quietleader.com
@davehava.bsky.social
Former Chief Scientific Officer at Synlogic, Metera Pharmaceuticals and Pulmatrix. Microbiologist, immunologist and drug developer. Opinions are my own.
@statesdj.bsky.social
Chief Science/Medical Officer Angstrom Bio, Austin, TX COI: Our company is developing high throughput diagnostics @[email protected] @[email protected]
@ricklivesey.bsky.social
Cellular and molecular neuroscience, neurodegeneration & drug discovery. Founder and CEO of Talisman Therapeutics & Gen2 Neuroscience, honorary prof at UCL. Cambridge UK.
@evertbosdriesz.bsky.social
assistant professor @VU Amsterdam | physicist turned computational biology | cancer biology | single cell | signal transduction https://evertbosdriesz.github.io
@gilman.bsky.social
Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player and mixologist, #immigrant, #BioSky. CEO, Arrakis Therapeutics and a variety of other things. https://www.michaelgilman.net/disclosures/
@bsky.app
official Bluesky account (check username👆) Bugs, feature requests, feedback: [email protected]